Skip to main content

Search
Search
Play/Pause

Order samples quickly and easily

We will send you samples and training materials to pass along to your patients.

Order samples

Rest assured, we’ve got your patients covered

OneTouch® test strips have the lowest co-pay on the most health plans± and are always covered by Medicare Part B.§

Learn more about insurance

OneTouch Reveal® mobile and web apps for diabetes

Learn how the OneTouch Reveal® mobile and web apps can help you have meaningful conversations with patients.

Learn more about our apps

ColorSure® technology instantly shows when blood glucose numbers are in or out of range.

Patients were four times more likely to take action on a blood glucose result with ColorSure® technology compared to a result without color^+

Download brochure

Pharmacy Resources

As a pharmacist, you are a valuable resource to your patients. Access the LearnSomething educational program and other downloadable resources to help prepare you and your staff to answer patient questions.

Go to pharmacy resources

*Compared to using a meter without a color range indicator and a paper logbook.

†During a 3-month period in a 24-week study conducted in the UK in 2016 with 128 patients (79 Type 1 and 49 Type 2 diabetes). 82% of 62 respondents agreed the OneTouch Reveal® mobile app detected patterns and 80% of 51 respondents agreed they were able to correct the underlying cause of these patterns to get their blood sugar back in range.

‡Treatment decisions should be based on the numerical results and healthcare professional’s recommendations and not solely on where results fall within the range limits.

±Some health plans may have more than one brand available at the lowest co-pay.

§Coverage and payment subject to co-insurance, deductible and patient eligibility requirements. LifeScan does not guarantee coverage or payment.

^In a clinical study conducted in the U.K. with 103 patients. 64 said they would prefer to act on a blood glucose result with color compared to 16 who preferred no color. And 23 had no preference. The study was conducted using simulated images

+Patients are not to make treatment decisions based on the range indicator feature. Treatment decisions should be based on the numerical result and healthcare professional’s recommendation and not solely on where the result falls within the range limits.

US-OTB-1900012